MedTrace Logo

Vitamin D Pilot Study in Patients With Multiple Sclerosis

NCT01257958 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2015-10-05

No results posted yet for this study

Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Conditions

  • Relapsing Remitting Multiple Sclerosis

Interventions

DRUG

19 nor vitamin d

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-02-28
Primary Completion
2000-02-29
Completion
2000-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257958 on ClinicalTrials.gov